SCHEMBL5599191

SCHEMBL5599191

COc1ccc(OC)c2c(-c3ccccc3)c3c(C)ccc(C)c3c(-c3ccccc3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.40
PDE4B Q07343 2/20 0.40
PDE4C Q08493 2/20 0.40
PDE4D Q08499 2/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
ALDH1A1 P00352 5/20 0.39
CYP3A4 P08684 2/20 0.39
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39
FABP5 Q01469 1/20 0.39
MAPT P10636 7/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20970991 0.80 MAPT (0.48) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL8335880 0.78 FABP3 (0.43) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL11249754 0.78 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL21636231 0.76 MAPT (0.48) CA12CA1CA2CA4CA7
SCHEMBL10177353 0.76 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL28245634 0.76 ALDH1A1 (0.41) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL15199338 0.76 L3MBTL1 (0.39) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL9876280 0.74 CA1 (0.50) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL12994038 0.74 ALDH1A1 (0.45) PDE4APDE4BPDE4CPDE4DCA12
SCHEMBL28390368 0.73 MAOA (0.45) PDE4APDE4BPDE4CPDE4DCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312605-B1 Method for producing biaryl compounds SUMITOMO CHEMICAL CO (JP) 2007-04-25 EP disclosed
US-7122711-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-10-17 US disclosed
US-20030158419-A1 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2003-08-21 US disclosed
EP-1312605-A1 Method for producing biaryl compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158419-A1 Method for producing biaryl compound B2M, BMI1, CYP2W1 PDE4A 4754/4885PDE4B 4524/4885PDE4C 4690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.